References

Gerlini G, Romagnoli P, Pimpinelli N. Skin cancer and immunosuppression. Crit Rev Oncol Hematol. 2005; 56:(1)127-136 https://doi.org/10.1016/j.critrevonc.2004.11.011

Healy R, Sahota A. The management of pruritus in the elderly. Mims Dermatology. 2007; 3:(4)40-42

Jensen P, Hansen S, Moller B Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol. 1999; 40:(2 Pt 1)177-186

Krynitz B, Edgren G, Lindelof B Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008—a Swedish population-based study. Int J Cancer. 2013; 132:(6)1429-1438 https://doi.org/10.1002/ijc.27765

National Institute for Health and Care Excellence. Improving outcomes for people with skin tumours including melanoma (update). CSG8. 2010. http://tinyurl.com/y9npxt54 (accessed 12 March 2019)

National Institute for Health and Care Excellence. Psoriasis: assessment and management. CG153. 2012. http://tinyurl.com/yb9s46bu (accessed 12 March 2019)

Skin cancers in transplant patients. 2019. http://tinyurl.com/y2ofqgs2 (accessed 14 March 2019)

Eczema research news. 2019. https://tinyurl.com/y3w9n6bt (accessed 19 March 2019)

Peters J. Drawing up a skin care plan for residents with eczema. Nursing and Residential Care. 2019; 21:(4)2-6

Ryder SA, Stannard CF. Treatment of chronic pain: antidepressant, antiepileptic and antiarrhythmic drugs. BJA Educ. 2005; 5:(1)18-21 https://doi.org/10.1093/bjaceaccp/mki003

Silverwood RJ, Forbes HJ, Abuabara K Severe and predominantly active atopic eczema in adulthood and long term risk of cardiovascular disease: population based cohort study. BMJ. 2018; 361 https://doi.org/10.1136/bmjk1786

Schofield JK, Fleming D, Grindlay D, Williams H. Skin conditions are the commonest new reason people present to general practitioners in England and Wales. Br J Dermatol. 2011; 165:(5)1044-1050 https://doi.org/10.1111/j.1365-2133.2011.10464.x

Managing the skin manifestations of systemic conditions

02 April 2019
Volume 24 · Issue 4

Skin complications of systemic diseases are common in general practice, as diseases in every organ system can have skin symptoms. Additionally, the majority of the systemic medications used in the treatment of various conditions have a list of potential side effects involving the skin, for example, rashes, pruritus and urticaria. Alternatively, they might exacerbate existing skin conditions, for example, live vaccines for shingles or beta-blockers for psoriasis.

Patients presenting with skin conditions represent 24% of all GP appointments requiring medical intervention (Schofield et al, 2011). It is particularly difficult for patients to come to terms with a skin condition, as the majority of treatments are topical applications of leave-on medication, leading to considerable discomfort. Further, one of the main symptoms of most skin conditions—itching as well as the reaction of scratching—can be very distressing as it can take over the patient's life, leading to loss of sleep and detrimentally affecting quality of life.

Register now to continue reading

Thank you for visiting Community Nursing and reading some of our peer-reviewed resources for district and community nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • New content and clinical newsletter updates each month